Association of hand-grip strength and non-alcoholic fatty liver disease index in older adults (original) (raw)

1. Statistics Korea. Elderly statistics 2017. Statistics Korea 2017;14-9.

2. Wu F, Guo Y, Kowal P, Jiang Y, Yu M, Li X, Zheng Y, Xu J. Prevalence of major chronic conditions among older Chinese adults: the Study on Global AGEing and adult health (SAGE) wave 1. PLoS One 2018;8:e74176.
crossref

3. Bertolotti M, Lonardo A, Mussi C, Baldelli E, Pellegrini E, Ballestri S, Romagnoli D, Loria P. Nonalcoholic fatty liver disease and aging: epidemiology to management. World J Gastroenterol 2014;20:4185-204. PMID: 10.3748/wjg.v20.i39.14185.
crossref

4. Koehler EM, Schouten JN, Hansen BE, van Rooij FJ, Hofman A, Stricker BH, Janssen HL. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol 2012;57:1305-11. PMID: 10.1016/j.jhep.2012.07.028. PMID: 22871499.
crossref

5. Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, Ratziu V, McCullough A. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 2011;54:344-53. PMID: 10.1002/hep.24376. PMID: 21520200.
crossref

6. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9. PMID: 10.1016/s0016-5085(99)70506-8. PMID: 10348825.
crossref

8. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J., Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018;15:11-20. PMID: 28930295.
crossref pdf

9. Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL, Wagenknecht LE, Pi-Sunyer FX, Kahn SE, Clark JM. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care 2010;33:2156-63. PMID: 10.2337/dc10-0856. PMID: 20664019.
crossref

10. Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol 2018;67:829-46.
crossref

11. Oh S, So R, Shida T, Matsuo T, Kim B, Akiyama K, Isobe T, Okamoto Y, Tanaka K, Shoda J. High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease. Sci Rep 2017;7:43029PMID: 10.1038/srep43029. PMID: 28223710.
crossref pdf

12. Amati F, Dubé JJ, Coen PM, Stefanovic-Racic M, Toledo FG, Goodpaster B. Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes Care 2009;32:1547-9. PMID: 10.2337/dc09-0267. PMID: 19401446.
crossref

13. Peng TC, Wu LW, Chen WL, Liaw FY, Chang YW, Kao TW. Nonalcoholic fatty liver disease and sarcopenia in a Western population (NHANES III): The importance of sarcopenia definition. Clin Nutr 2017;S0261-5614:31419-X.
crossref

14. Whitsett M, VanWagner LB. Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review. World J Hepatol 2015;7:2041-52. PMID: 10.4254/wjh.v7.i16.2041. PMID: 26261693.
crossref

15. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Zvibel I, Goldiner I, Blendis L, Halpern Z, Oren R. Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study. Hepatology 2008;48:1791-8. PMID: 10.1002/hep.22525. PMID: 18972405.
crossref

16. Tsunoda K, Kai Y, Uchida K, Kuchiki T, Nagamatsu T. Physical activity and risk of fatty liver in people with different levels of alcohol consumption: a prospective cohort study. BMJ Open 2014;4:e005824PMID: 10.1136/bmjopen-2014-005824.
crossref

17. Cho SH, Hahm SK, Seo YN, Kim KU, Kim JY, Park JA. The association of non-alcoholic fatty liver disease and physical activity. J Korean Acad Fam Med 2008;29:513-9.

18. Kantartzis K, Thamer C, Peter A, Machann J, Schick F, Schraml C, Königsrainer A, Königsrainer I, Kröber S, Niess A, Fritsche A, Häring HU, Stefan N. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut 2009;58:1281-8. PMID: 10.1136/gut.2008.151977. PMID: 19074179.
crossref

19. Church TS, Kuk JL, Ross R, Priest EL, Biltoft E, Blair SN. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology 2006;130:2023-30. PMID: 10.1053/j.gastro.2006.03.019. PMID: 16762625.
crossref

20. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults--United States, 1992, and changes in the definition of current cigarette smoking. Morb Mortal Wkly Rep 1994;43:342-6.

21. Rantakömi SH, Kurl S, Sivenius J, Kauhanen J, Laukkanen JA. The frequency of alcohol consumption is associated with the stroke mortality. Acta Neurol Scand 2014;130:118-24. PMID: 10.1111/ane.12243. PMID: 24606050.
crossref

22. Oh JY, Yang YJ, Kim BS, Kang JH. Validity and reliability of Korean version of international physical activity questionnaire (IPAQ) short form. J Korean Acad Fam Med 2007;28:532-41.

23. Lee YH, Bang H, Park YM, Bae JC, Lee BW, Kang ES, Cha B, Lee HC, Balkau B, Lee WY, Kim DJ. Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores. PLoS One 2014;9:e107584PMID: 10.1371/journal.pone.0107584. PMID: 25216184.
crossref pmid pmc

24. Committee for the Korean Guidelines for the Management of Dyslipidemia. 2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation). Korean Circ J 2016;46:275-306. PMID: 10.4070/kcj.2016.46.3.275. PMID: 27275165.
crossref

25. Korean Diabetes Association. 2015 Treatment guidelines for diabetes. 5th edition. Korean Diabetes Association 2015;6-9.

26. Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH, Sung MW, Lee HS. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 2010;42:503-8. PMID: 10.1016/j.dld.2009.08.002. PMID: 19766548.
crossref

27. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K, Sanderson SO, Lenzi M, Adams LA, Kench J, Therneau TM, Day CP. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007;45:846-54. PMID: 10.1002/hep.21496. PMID: 17393509.
crossref

28. Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2014;20:475-85. PMID: 10.3748/wjg.v20.i2.475. PMID: 24574716.
crossref

29. Meng G, Wu H, Fang L, Li C, Yu F, Zhang Q, Liu L, Du H, Shi H, Xia Y, Guo X, Liu X, Bao X, Su Q, Gu Y, Yang H, Bin Yu, Wu Y, Sun Z, Niu K. Relationship between grip strength and newly diagnosed nonalcoholic fatty liver disease in a large-scale adult population. Sci Rep 2016;6:33255PMID: 10.1038/srep33255. PMID: 27616599.
crossref pdf

30. Lee Y. Diagnosis of non-alcoholic fatty liver disease based on clinical and laboratory data. J Korean Diabetes 2017;18:102-8. PMID: 10.4093/jkd.2017.18.2.102.
crossref

31. Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 2013;57:1357-65. PMID: 10.1002/hep.26156. PMID: 23175136.
crossref

32. Asp M, Simonsson B, Larm P, Molarius A. Physical mobility, physical activity, and obesity among elderly: findings from a large population-based Swedish survey. Public Health 2017;147:84-91. PMID: 10.1016/j.puhe.2017.01.032. PMID: 28404503.
crossref

33. Krasnoff JB, Painter PL, Wallace JP, Bass NM, Merriman RB. Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2008;47:1158-66. PMID: 10.1002/hep.22137. PMID: 18266250.
crossref

34. Nagano M, Sasaki H, Kumagai S. Association of cardiorespiratory fitness with elevated hepatic enzyme and liver fat in Japanese patients with impaired glucose tolerance and type 2 diabetes mellitus. J Sports Sci Med 2010;9:405-10. PMID: 24149634.

35. Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology 2014;59:1772-8. PMID: 10.1002/hep.26716. PMID: 23996808.
crossref

36. Bouchard DR, Dionne IJ, Brochu M. Sarcopenic/obesity and physical capacity in older men and women: data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study. Obesity (Silver Spring) 2009;17:2082-8. PMID: 10.1038/oby.2009.109. PMID: 19373219.
crossref

37. Zhai Y, Xiao Q, Miao J. The Relationship between NAFLD and Sarcopenia in Elderly Patients. Can J Gastroenterol Hepatol 2018;2018:5016091PMID: 10.1155/2018/5016091. PMID: 29785395.
crossref pdf